Guidelines and Consensus Statements

Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies
Kristin G Anderson, David A Braun, Aitziber Buqué, Sarah B Gitto, Jennifer L Guerriero, Brendan Horton, Bridget P Keenan, Teresa S Kim, Abigail Overacre-Delgoffe, Marco Ruella, Todd A Triplett, Omkara Veeranki, Vivek Verma, Fan Zhang

Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e006533; DOI: 10.1136/jitc-2022-006533
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer
Mary L Disis, Sarah F Adams, Jyoti Bajpai, Marcus O Butler, Tyler Curiel, Shelley A Dodt, Laura Doherty, Leisha A Emens, Claire F Friedman, Margaret Gatti-Mays, Melissa A Geller, Amir Jazaeri, Veena S John, Katherine C Kurnit, John B Liao, Haider Mahdi, Anne Mills, Emese Zsiros, Kunle Odunsi

Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e006624; DOI: 10.1136/jitc-2022-006624
Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop
Guy Travis Clifton, Mace Rothenberg, Paolo Antonio Ascierto, Glenn Begley, Michael Cecchini, Joseph Paul Eder, Francois Ghiringhelli, Antoine Italiano, Marina Kochetkova, Rong Li, Fatima Mechta-Grigoriou, Sara I Pai, Paolo Provenzano, Ellen Puré, Antoni Ribas, Kurt A Schalper, Wolf Herve Fridman

Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e006773; DOI: 10.1136/jitc-2023-006773
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancer
Ronan J Kelly, Katherine Bever, Joseph Chao, Kristen K Ciombor, Cathy Eng, Marwan Fakih, Lipika Goyal, Joleen Hubbard, Renuka Iyer, Holly T Kemberling, Smitha Krishnamurthi, Geoffrey Ku, Mindy Mintz Mordecai, Van K Morris, Andrew Scott Paulson, Valerie Peterson, Manish A Shah, Dung T Le

Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e006658; DOI: 10.1136/jitc-2022-006658
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs
Tian Zhang, Patrick M Forde, Ryan J Sullivan, Elad Sharon, Elizabeth Barksdale, Wendy Selig, Scot Ebbinghaus, Gina Fusaro, Damla Gunenc, Dena Battle, Robyn Burns, Marc S Hurlbert, Mark Stewart, Michael B Atkins

Journal for ImmunoTherapy of Cancer May 2023, 11 (5) e006555; DOI: 10.1136/jitc-2022-006555
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
Jarushka Naidoo, Catherine Murphy, Michael B Atkins, Julie R Brahmer, Stephane Champiat, David Feltquate, Lee M Krug, Javid Moslehi, M Catherine Pietanza, Joanne Riemer, Caroline Robert, Elad Sharon, Maria E Suarez-Almazor, Karthik Suresh, Michelle Turner, Jeffrey Weber, Laura C Cappelli

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e006398; DOI: 10.1136/jitc-2022-006398
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors
Harriet Kluger, J Carl Barrett, Justin F Gainor, Omid Hamid, Michael Hurwitz, Theresa LaVallee, Rebecca A Moss, Roberta Zappasodi, Ryan J Sullivan, Hussein Tawbi, Elad Sharon

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e005921; DOI: 10.1136/jitc-2022-005921
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies
Michael B Atkins, Paolo A Ascierto, David Feltquate, James L Gulley, Douglas B Johnson, Nikhil I Khushalani, Jeffrey Sosman, Timonthy A Yap, Harriet Kluger, Ryan J Sullivan, Hussein Tawbi

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e005923; DOI: 10.1136/jitc-2022-005923
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy
Naiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, Helen X Chen, Robert L Ferris, Sarah B Goldberg, Matthew D Hellmann, Ranee Mehra, Ina Rhee, Jong Chul Park, Harriet Kluger, Hussein Tawbi, Ryan J Sullivan

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e005920; DOI: 10.1136/jitc-2022-005920
Z-DNA enhances immunotherapy by triggering death of inflammatory cancer-associated fibroblasts
Alan Herbert, Siddharth Balachandran

Journal for ImmunoTherapy of Cancer Nov 2022, 10 (11) e005704; DOI: 10.1136/jitc-2022-005704

Main menu

Guidelines and Consensus Statements

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Guidelines and Consensus Statements

Pages